BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32207251)

  • 1. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
    Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
    Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.
    Zhang L; Yu H; Badzio A; Boyle TA; Schildhaus HU; Lu X; Dziadziuszko R; Jassem J; Varella-Garcia M; Heasley LE; Kowalewski AA; Ellison K; Chen G; Zhou C; Hirsch FR
    J Thorac Oncol; 2015 Jul; 10(7):1083-90. PubMed ID: 26020126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
    Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
    Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC).
    Guo Q; Sun Y; Yu S; Bai H; Zhao J; Zhuo M; Wang J
    Thorac Cancer; 2017 Mar; 8(2):73-79. PubMed ID: 28008744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.
    Thomas A; Lee JH; Abdullaev Z; Park KS; Pineda M; Saidkhodjaeva L; Miettinen M; Wang Y; Pack SD; Giaccone G
    J Thorac Oncol; 2014 Apr; 9(4):567-71. PubMed ID: 24736083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer.
    Schultheis AM; Bos M; Schmitz K; Wilsberg L; Binot E; Wolf J; Büttner R; Schildhaus HU
    Mod Pathol; 2014 Feb; 27(2):214-21. PubMed ID: 23887299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
    Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
    Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers.
    Paik PK; Shen R; Berger MF; Ferry D; Soria JC; Mathewson A; Rooney C; Smith NR; Cullberg M; Kilgour E; Landers D; Frewer P; Brooks N; André F
    Clin Cancer Res; 2017 Sep; 23(18):5366-5373. PubMed ID: 28615371
    [No Abstract]   [Full Text] [Related]  

  • 11. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.
    Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S
    Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice.
    Ferone G; Song JY; Krijgsman O; van der Vliet J; Cozijnsen M; Semenova EA; Adams DJ; Peeper D; Berns A
    Cell Rep; 2020 Mar; 30(11):3837-3850.e3. PubMed ID: 32187553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.
    Sousa V; Reis D; Silva M; Alarcão AM; Ladeirinha AF; d'Aguiar MJ; Ferreira T; Caramujo-Balseiro S; Carvalho L
    Virchows Arch; 2016 Aug; 469(2):173-82. PubMed ID: 27194548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
    Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
    Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 amplification in squamous cell carcinoma of the lung.
    Heist RS; Mino-Kenudson M; Sequist LV; Tammireddy S; Morrissey L; Christiani DC; Engelman JA; Iafrate AJ
    J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.
    Clauditz TS; Böttcher A; Hanken H; Borgmann K; Sauter G; Wilczak W; Grob T; Münscher A
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):53-61. PubMed ID: 29022097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
    Lim SH; Sun JM; Choi YL; Kim HR; Ahn S; Lee JY; Lee SH; Ahn JS; Park K; Kim JH; Cho BC; Ahn MJ
    Cancer; 2016 Oct; 122(19):3024-31. PubMed ID: 27315356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic impact of CD49b in human lung cancer.
    Tirilomi A; Elakad O; Yao S; Li Y; Hinterthaner M; Danner BC; Ströbel P; Tirilomis T; Bohnenberger H; von Hammerstein-Equord A
    Medicine (Baltimore); 2022 Feb; 101(6):e28814. PubMed ID: 35147120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
    Schildhaus HU; Heukamp LC; Merkelbach-Bruse S; Riesner K; Schmitz K; Binot E; Paggen E; Albus K; Schulte W; Ko YD; Schlesinger A; Ansén S; Engel-Riedel W; Brockmann M; Serke M; Gerigk U; Huss S; Göke F; Perner S; Hekmat K; Frank KF; Reiser M; Schnell R; Bos M; Mattonet C; Sos M; Stoelben E; Wolf J; Zander T; Buettner R
    Mod Pathol; 2012 Nov; 25(11):1473-80. PubMed ID: 22684217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.